Skip to main content
. 2021 Mar 26;10(3):e25085. doi: 10.2196/25085

Table 3.

Study phase 2b–subsequent validation: online Australian diabetes-specific quality of life, MOS SF-36, DQOL, and PAID-20 questionnaires completed by adults with type 1 diabetes mellitus (n=100).

Questionnaire section Brief description of items Source
Section 1: information sheeta Overview of the study N/Ab
Section 2: screening questionsc Assessment of study eligibility N/A
Section 3: consent forma Signed by participant N/A
Section 4: Australian diabetes-specific quality of life questionnaire A 28-item questionnaire containing 4 constructs measuring diabetes quality of life using a 10-point Likert scale from “very strongly disagree” to “very strongly agree” Adapted from [48,57]

Section 5: MOS SF-36d Measures of physical and psychological constructs of general well-being with varying response scales [52]

Section 6: DQOLe A 43-item instrument consisting of 4 constructs (satisfaction, impact, social/vocational worry, diabetes-related worry). A Likert response format from “very satisfied” to “not satisfied” for the satisfaction construct and from “never” to “always” for the other constructs. [49]

Section 7: PAID-20f A 20-item questionnaire that measures diabetes-related distress. Each item addresses a different issue associated with diabetes. A 5-point response scale is used from “not a problem to “serious problem”. [53]
Section 8: sociodemographic covariates Data collection: gender, age, height, weight, diabetes duration, occupation, level of education, etc Adapted from [61-63]

aParticipant information and consent form are to be completed online.

bN/A: not applicable.

cScreening questions are to be completed online. The response to each question is yes or no. The questions include the following: “I have type 1 diabetes mellitus,” “I am 18 years or older,” and “I have had type 1 diabetes mellitus for one year or longer.”

dMOS SF-36: Medical Outcomes Study 36-Item Short Form Health Survey.

eDQOL: Diabetes Quality of Life Measure.

fPAID-20: Problem Areas in Diabetes.